GNG2

GNG2 is the γ2 subunit of heterotrimeric G proteins that couples chemokine and lipid receptor signaling to cytoskeletal and migratory output, and acts as a growth-suppressive node in multiple cancers (PMID:38270191, PMID:35322009). In B cells, GNG2 transduces signals from chemoattractant receptors responding to Cxcl12, Cxcl13, and S1P, driving Ca2+ mobilization, F-actin polymerization, and directed positioning in the spleen; its protein abundance is set by the deubiquitylase Otub1, which removes ubiquitin to stabilize GNG2, so that Otub1 loss increases GNG2 ubiquitylation and reshapes chemotactic responsiveness (PMID:38270191). In tumor cells, GNG2 functions as a suppressor of proliferation and invasion: it directly binds MRAS at the cell membrane to dampen ERK and AKT activity (PMID:35322009), and its overexpression lowers c-SRC, AKT, and FAK activity while elevating p21, restraining migration, invasion, and PI3K/AKT/mTOR signaling and imposing G0/G1 arrest and apoptosis across melanoma, breast, and colorectal cancer models (PMID:23031273, PMID:24660107, PMID:39805936).

1. 2012 Medium

   Established that GNG2 is not merely a passive G-protein subunit but a regulator of tumor cell proliferation, linking it to c-SRC/AKT signaling and the cell-cycle inhibitor p21.

   Evidence bidirectional GNG2 overexpression and siRNA knockdown in melanoma cells with signaling western blots and xenografts

   PMID:23031273

   Open questions at the time

   • How GNG2 mechanistically lowers c-SRC/AKT activity not resolved
   • Direct molecular partner mediating the effect not identified
2. 2014 Medium

   Extended GNG2's suppressive role from proliferation to invasion by tying it to focal adhesion kinase activity.

   Evidence GNG2 gain/loss-of-function in melanoma cells with migration/invasion assays and phospho-FAK readout

   PMID:24660107

   Open questions at the time

   • Whether GNG2 acts directly on FAK or upstream unclear
   • Single tumor type tested
3. 2021 Low

   Placed GNG2 downstream of an ion channel regulator, showing it is required for the anti-tumor phenotype of KCNJ2 loss in thyroid carcinoma.

   Evidence double siRNA epistasis of KCNJ2 and GNG2 in thyroid carcinoma lines with EMT marker readouts

   PMID:34212982

   Open questions at the time

   • Mechanism by which KCNJ2 regulates GNG2 expression unknown
   • Single lab, no in vivo confirmation
4. 2022 Medium

   Identified a direct molecular partner explaining GNG2's growth suppression — membrane MRAS binding linked to ERK/AKT downregulation.

   Evidence FRET demonstration of direct GNG2-MRAS interaction with phospho-ERK/AKT, apoptosis, proliferation, and xenograft assays in breast cancer

   PMID:35322009

   Open questions at the time

   • Structural basis of GNG2-MRAS binding not defined
   • Whether this interaction operates outside breast cancer untested
5. 2024 High

   Defined how GNG2 protein levels are controlled, identifying Otub1-mediated deubiquitylation as a stability switch governing GNG2-dependent B cell chemotaxis.

   Evidence reciprocal Co-IP, ubiquitylation assays, BioID proximal mapping, and Otub1-KO murine B cells with Ca2+, F-actin, chemotaxis, and in vivo splenic readouts

   PMID:38270191

   Open questions at the time

   • E3 ligase that ubiquitylates GNG2 not identified
   • Whether Otub1 regulates GNG2 in non-immune/cancer contexts unknown
6. 2025 Medium

   Consolidated the tumor-suppressor model by showing GNG2 enforces G0/G1 arrest and blocks metastasis via PI3K/AKT/mTOR inhibition.

   Evidence GNG2 overexpression in colorectal cancer cells with cell-cycle analysis, pathway western blots, and orthotopic xenograft with brain metastasis readout

   PMID:39805936

   Open questions at the time

   • Direct receptor or partner driving PI3K/AKT/mTOR suppression in CRC not pinpointed
   • Single lab

• It remains unresolved how GNG2's canonical role as a Gβγ chemotaxis effector mechanistically connects to its tumor-suppressive MRAS/AKT/FAK functions, and which receptors and E3 ligases integrate these activities.
• Unified mechanism linking G-protein signaling and growth suppression absent
• E3 ligase for GNG2 ubiquitylation unidentified
• Structural detail of GNG2 partner interactions lacking